Panagora Asset Management Inc Compass Therapeutics, Inc. Transaction History
Panagora Asset Management Inc
- $21.7 Billion
- Q2 2025
A detailed history of Panagora Asset Management Inc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 15,840 shares of CMPX stock, worth $67,320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,840
Previous 170,607
90.72%
Holding current value
$67,320
Previous $324,000
87.35%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CMPX
# of Institutions
104Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$64.7 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$57.4 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$42.6 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$30.4 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$28.1 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $430M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...